Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahed Kamal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Gastroenterology|July 26, 2024
Comment on: [10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study]Shahed Kamal, Jonathan P Segal
Cureus|June 1, 2023
Trends in Tuberculosis Mortality Across India: Improvements Despite the COVID-19 PandemicKaran Varshney, Hinal Patel, Shahed Kamal
Cureus|April 16, 2025
Infection Risk in Biological Disease-Modifying Anti-rheumatic DrugsMourushi Isa, Ma Rosario Rufina Ramos, Shahed Kamal
Cureus|May 23, 2024
Endoscopic Visualization of the Embolization Coil With Subsequent Endoscopic Therapy: A Case ReportShahed Kamal, Karan Varshney, Sheng-Weng Lo, et al.
Journal of Clinical Medicine|September 28, 2023
Are We Ready to Reclassify Crohn's Disease Using Molecular Classification?Shahed Kamal, Nikita Parkash, William Beattie, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2024
Systematic review with meta-analysis of the effectiveness of subcutaneous biologics versus intravenous biologics in inflammatory bowel diseasesAlexander T Elford, Rishni Heldt, Shahed Kamal, et al.
Inflammatory Bowel Diseases|April 12, 2023
Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisYakup Kilic, Shahed Kamal, Farah Jaffar, et al.
Cureus|May 13, 2024
Risk Factors and Clinical Characteristics of Pandrug-Resistant Pseudomonas aeruginosaShahed Kamal, Karan Varshney, Danielle J Uayan, et al.
Clinical Medicine (London, England)|December 8, 2023
Crohn's disease: an updateElla Cockburn, Shahed Kamal, Andrea Chan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Gastroenterology|July 26, 2024
Comment on: [10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study]Shahed Kamal, Jonathan P Segal
Cureus|June 1, 2023
Trends in Tuberculosis Mortality Across India: Improvements Despite the COVID-19 PandemicKaran Varshney, Hinal Patel, Shahed Kamal
Cureus|April 16, 2025
Infection Risk in Biological Disease-Modifying Anti-rheumatic DrugsMourushi Isa, Ma Rosario Rufina Ramos, Shahed Kamal
Cureus|May 23, 2024
Endoscopic Visualization of the Embolization Coil With Subsequent Endoscopic Therapy: A Case ReportShahed Kamal, Karan Varshney, Sheng-Weng Lo, et al.
Journal of Clinical Medicine|September 28, 2023
Are We Ready to Reclassify Crohn's Disease Using Molecular Classification?Shahed Kamal, Nikita Parkash, William Beattie, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2024
Systematic review with meta-analysis of the effectiveness of subcutaneous biologics versus intravenous biologics in inflammatory bowel diseasesAlexander T Elford, Rishni Heldt, Shahed Kamal, et al.
Inflammatory Bowel Diseases|April 12, 2023
Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisYakup Kilic, Shahed Kamal, Farah Jaffar, et al.
Cureus|May 13, 2024
Risk Factors and Clinical Characteristics of Pandrug-Resistant Pseudomonas aeruginosaShahed Kamal, Karan Varshney, Danielle J Uayan, et al.
Clinical Medicine (London, England)|December 8, 2023
Crohn's disease: an updateElla Cockburn, Shahed Kamal, Andrea Chan, et al.
Pageof 1